C4 Therapeutics, Inc. - COM STK (CCCC)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM STK
Shares, excl. options Q3 2024
64M
Holdings value Q3 2024
$365M
Value change Q3 2024
+$20.3M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
117
Number of buys Q3 2024
65
Number of sells Q3 2024
-56
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 64M $365M +$20.3M $5.70 120
2024 Q2 60.9M $281M +$6.92M $4.62 114
2024 Q1 58M $474M +$92.5M $8.17 103
2023 Q4 47M $266M +$85.4M $5.65 91
2023 Q3 34.7M $64.5M -$105K $1.86 82
2023 Q2 34.2M $94.1M -$9.39M $2.75 95
2023 Q1 37.4M $117M -$15.2M $3.14 116
2022 Q4 39.2M $231M -$9.77M $5.90 111
2022 Q3 39.4M $346M -$2.27M $8.77 113
2022 Q2 39.4M $297M -$40.1M $7.54 112
2022 Q1 37.3M $904M +$6.18M $24.26 118
2021 Q4 35.9M $1.15B +$16.7M $32.20 116
2021 Q3 34.5M $1.54B +$111M $44.68 110
2021 Q2 31.9M $1.21B +$260M $37.84 107
2021 Q1 25.1M $927M +$90.4M $36.99 83
2020 Q4 22.7M $744M +$719M $33.13 75